Aimei Health Technology Co., Ltd
AFJKR
NASDAQ Global Market0.10
USD
-0.02
- -
Aimei Health Technology Co., Ltd
AFJKR
(NASDAQ Global Market)
Recent
price
0.10
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Aimei Health Technology Co., Ltd Aimei Health Technology Co., Ltd (AFJKR) operates as a blank check company incorporated in the Cayman Islands for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses, primarily targeting small-cap companies in the biopharmaceutical, medical technology and device industries, diagnostics, and related services sectors domiciled in North America, Europe, or the Asia Pacific regions; the company generates no significant operating revenue and relies on interest income from its trust account assets, which include U.S. government securities and money market funds. Headquartered at 10 East 53rd Street, Suite 3001, New York, NY, the company was founded on April 27, 2023, with its sponsor Aimei Investment Ltd providing initial support through private unit purchases and extension funding. Its securities trade on Nasdaq under the symbols AFJK (ordinary shares), AFJKR (rights exchangeable for one-fifth of one ordinary share), and AFJKU (units comprising one ordinary share and one right). The company completed its initial public offering on December 6, 2023, pricing 6,900,000 units at $10.00 each for gross proceeds of $69 million, including the full exercise of the underwriters' over-allotment option, with concurrent private placement of 332,000 units to its sponsor generating $3.32 million; approximately $69.69 million of net proceeds were placed into a trust account at an initial value of $10.10 per unit. As of June 30, 2025, trust assets stood at $44.51 million following significant redemptions of 2,904,267 public shares on February 5, 2025, at approximately $10.77 per share totaling $31.27 million. The company maintains an administrative services agreement with its sponsor and holds a deferred underwriter fee of $690,000. Key recent developments include entering a definitive Business Combination Agreement on June 19, 2024, with United Hydrogen Group Inc. and affiliates, pursuant to which a newly formed public entity (Pubco) would acquire United Hydrogen via a first merger and subsequently merge with Aimei Health via a second merger, subject to shareholder approval and customary closing conditions; the agreement remains pending as of the latest filings. To extend its combination deadline from an initial 12 months post-IPO to up to 24 months, the company has executed nine one-month extensions through August 6, 2025, depositing a total of approximately $1.21 million into the trust account via unsecured promissory notes issued to its sponsor and United Hydrogen Group Inc., with the most recent on October 9, 2025, pushing the termination date to November 6, 2025; these extensions, adjusted to a flat $150,000 monthly fee after the second, reflect ongoing efforts to consummate the transaction amid redemptions and liquidity constraints evidenced by a working capital deficit of $2.17 million as of June 30, 2025. On June 6, 2025, the company amended aspects of the merger agreement as disclosed in SEC filings. No operating products or services exist pending business combination completion.
AIMEI HEALTH TECHNOLOGY CO., LTD. ANNOUNCES TERMINATION OF BUSINESS COMBINATION AGREEMENT WITH UNITED HYDROGEN GROUP INC.
Short Interest in Aimei Health Technology Co., Ltd (NASDAQ:AFJKR) Increases By 158.5%
Aimei Health Technology Co., Ltd (NASDAQ:AFJKR) Sees Significant Decline in Short Interest
Aimei Health Technology Co., Ltd (NASDAQ:AFJKR) Sees Large Decrease in Short Interest
Aimei Health Technology Co., Ltd (NASDAQ:AFJKR) Short Interest Update
Aimei Health Technology Co., Ltd (NASDAQ:AFJKR) Short Interest Down 58.4% in October